Antiphospholipid Syndrome: A Rare Cause of Myocardial Infarction in Young Adults (Case Report and Review of the Literature)
Downloads
Acute coronary syndrome rarely occurs in young adults and is infrequently associated with antiphospholipid syndrome. We report the case of a 28-year-old man who presented for an acute myocardial infarction with ST-segment elevation myocardial infarction. He benefited from an urgent percutaneous transluminal coronary angioplasty. Hypercoagulability status studies were performed after the event, establishing the diagnosis of antiphospholipid syndrome. Our case highlights this syndrome as a rare cause of myocardial infarction in young adults.
S. Miyakis et al., « International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) », J. Thromb. Haemost. JTH, vol. 4, no 2, p. 295‑306, févr. 2006,
doi: 10.1111/j.1538-7836.2006.01753.x.
S. Nazir, N. Tachamo, S. Lohani, R. Hingorani, D. R. Poudel, et A. Donato, « Acute myocardial infarction and antiphospholipid antibody syndrome: a systematic review », Coron. Artery Dis., vol. 28, no 4, p. 332‑335, juin 2017, doi: 10.1097/MCA.0000000000000476.
H. En, « Clinical and serological features of the “antiphospholipid syndrome” », Brit J Rheumatol, vol. 26, p. 19, 1987.
J. C. Piette, « 1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a "mission impossible’? », Lupus, vol. 5, no 5, p. 354‑363, oct. 1996,
doi: 10.1177/096120339600500504.
M. Hojnik, J. George, L. Ziporen, et Y. Shoenfeld, « Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome », Circulation, vol. 93, no 8, p. 1579‑1587, avr. 1996, doi: 10.1161/01.cir.93.8.1579.
D. Erkan, Y. Yazici, R. Sobel, et M. D. Lockshin, « Primary antiphospholipid syndrome: functional outcome after 10 years », J. Rheumatol., vol. 27, no 12, p. 2817‑2821, déc. 2000.
A. Ogimoto, M. Sekiya, J. Funada, M. Miyagawa, Y. Kubo, et H. Akutsu, « Antiphospholipid syndrome with acute myocardial infarction and portal vein occlusion: a case report », Jpn. Circ. J., vol. 64, no 6, p. 468‑470, juin 2000, doi: 10.1253/jcj.64.468.
J. M. Thorp, N. C. Chescheir, et B. Fann, « Postpartum myocardial infarction in a patient with antiphospholipid syndrome », Am. J. Perinatol., vol. 11, no 1, p. 1‑3, janv. 1994, doi: 10.1055/s-2007-994522.
M. J. Cuadrado et al., « Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression », Arthritis Rheum., vol. 40, no 5, p. 834‑841, mai 1997, doi: 10.1002/art.1780400509.
L. Yh et al., « Changing Practice Pattern of Acute Coronary Syndromes in Taiwan from 2008 to 2015 », Acta Cardiol. Sin., vol. 35, no 1, janv. 2019,
doi: 10.6515/ACS.201901_35(1).20180716B.
P. Riboldi, M. Gerosa, et P. L. Meroni, « Statins and autoimmune diseases », Lupus, vol. 14, no 9, p. 765‑768, 2005, doi: 10.1191/0961203305lu2217oa.
P. L. Meroni et al., « Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome », J. Autoimmun., vol. 15, no 2, p. 237‑240, sept. 2000, doi: 10.1006/jaut.2000.0412.
All Content should be original and unpublished.
